Patents Assigned to SwitchGear Genomics, Inc.
  • Patent number: 9663823
    Abstract: This invention provides transcription regulatory control sequences, the activity of which function as biomarkers for a variety of biological responses. This invention also provides expression constructs in which a biomarker transcription regulatory sequence is operably linked with a sequence for a reporter. Cells that comprise these expression constructs can be used in assays to identify conditions that modulate activity of the biological response.
    Type: Grant
    Filed: July 13, 2014
    Date of Patent: May 30, 2017
    Assignee: SWITCHGEAR GENOMICS, INC.
    Inventors: Shelley Force Aldred, Nathan D. Trinklein, Michael Rose, Patrick Collins
  • Patent number: 9006405
    Abstract: This invention provides modified nucleotide sequences encoding luciferase that have greater expression than wild type luciferase.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: April 14, 2015
    Assignee: SwitchGear Genomics, Inc.
    Inventors: Nathan D. Trinklein, Shelley Force Aldred
  • Publication number: 20140364336
    Abstract: This invention provides transcription regulatory control sequences, the activity of which function as biomarkers for a variety of biological responses. This invention also provides expression constructs in which a biomarker transcription regulatory sequence is operably linked with a sequence for a reporter. Cells that comprise these expression constructs can be used in assays to identify conditions that modulate activity of the biological response.
    Type: Application
    Filed: July 13, 2014
    Publication date: December 11, 2014
    Applicant: SWITCHGEAR GENOMICS, INC.
    Inventors: Shelley Force Aldred, Nathan D. Trinklein, Michael Rose, Patrick Collins
  • Patent number: 8815779
    Abstract: This invention provides transcription regulatory control sequences, the activity of which function as biomarkers for a variety of biological responses. This invention also provides expression constructs in which a biomarker transcription regulatory sequence is operably linked with a sequence for a reporter. Cells that comprise these expression constructs can be used in assays to identify conditions that modulate activity of the biological response.
    Type: Grant
    Filed: September 16, 2009
    Date of Patent: August 26, 2014
    Assignee: SwitchGear Genomics, Inc.
    Inventors: Shelley Force Aldred, Nathan D. Trinklein, Michael Rose, Patrick Collins